A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 950 participants.
Also called NCT02796157
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 950 participants
- Sponsor
- Registry
-
NCT02796157
-
- Other papers using this trial's data
- Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02796157. Randomized; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2019-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions
- Condition
- Coronary Artery Disease
- Intervention (Device)
- PCI (percutaneous coronary intervention) with Absorb everolimus-eluting bioresorbable vascular scaffold
- Intervention (Device)
- PCI with Xience everolimus-eluting metallic stent
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02796157- Content hash
5e9e0c8c1b69f26505609ce484dc821dc5e1119d412b71c903e1929bf049090a